Showing results (211-220 of 443) with videos related to
Sort By:
Pageof 45
Biochemical and Biophysical Research Communications|March 22, 2008
Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasionYunge Zhao, Charles E Lyons, Aizhen Xiao, et al.Future Science OA|December 20, 2017
Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancerSaroj Niraula, Arnoud J Templeton, Francisco Vera-Badillo, et al.Oncotarget|March 31, 2018
Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancerAriadna Tibau, Geòrgia Anguera, Fernando Andrés-Pretel, et al.The Biochemical Journal|September 3, 2009
Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF)Janet V Cross, Joshua M Rady, Frank W Foss, et al.The Journal of Bone and Joint Surgery. American Volume|March 3, 2007
Measuring the attitudes and impact of the eighty-hour workweek rules on orthopaedic surgery residentsSharat K Kusuma, Samir Mehta, Michael Sirkin, et al.Cancers|July 12, 2025
Tumor Segmentation on PSMA PET/CT Predicts Survival in Biochemical Recurrence of Prostate Cancer: A Retrospective Study Using [68Ga]Ga-PSMA-11 and [18F]-PSMA-1007Ken Kudura, Yves Schaulin, Arnoud J Templeton, et al.Australian Journal of General Practice|March 5, 2025
'They made a hard day feel a little easier': Patients' experiences of an integrated crisis response following recent sexual assaultMary Stewart, David J Templeton, Julie Mooney-Somers, et al.Cancers|April 26, 2025
The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-AnalysisJonas A Zuellig, Roman Adam, Filomena Udry, et al.Journal of Virology|April 10, 1999
Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2J L Liu, Y Ye, Z Qian, et al.Cancer Treatment Reviews|February 2, 2016
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapiesA Srikanthan, F Vera-Badillo, J Ethier, et al.Pageof 45